| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |